Effect of exclusive enteral nutrition on the microbiota of children with newly diagnosed Crohn's disease

Clinical and Translational Gastroenterology

Volumn 6, Issue 1, 2015, Pages

  Kaakoush, Nadeem O ^a   Day, Andrew S ^a,b,c   Leach, Steven T ^a   Lemberg, Daniel A ^b   Nielsen, Shaun ^a   Mitchell, Hazel M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ACTINOBACTERIA; ADOLESCENT; ARTICLE; BACTEROIDETES; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DYSBIOSIS; ENTERIC FEEDING; FECES ANALYSIS; FECES MICROFLORA; FIRMICUTES; FUSOBACTERIA; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; META ANALYSIS; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; OPERATIONAL TAXONOMIC UNIT; PRIORITY JOURNAL; PROTEOBACTERIA; RECURRENT DISEASE; REMISSION; RNA GENE; SCHOOL CHILD; TAXONOMY; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 84927642638     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2014.21     Document Type: Article

References (48)

1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407.
2. Talley NJ, Abreu MT, Achkar JP et al. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011; 106: S2-25.
3. Heuschkel RB, Menache CC, Megerian JT et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8-15.
4. Breese EJ, Michie CA, Nicholls SW et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 1995; 9: 547-552.
5. Day AS, Whitten KE, Lemberg DA et al. Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol 2006; 21: 1609-1614.
6. Berni Canani R, Terrin G, Borrelli O et al. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 2006; 38: 381-387.
7. Critch J, Day AS, Otley A et al. Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2012; 54: 298-305.
8. Nahidi L, Leach ST, Sidler MA et al. Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. Inflamm Bowel Dis 2011; 17: 516-523.
9. Whitten KE, Leach ST, Bohane TD et al. Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease. J Gastroenterol 2010; 45: 399-405.
10. Day AS, Mitchell HM, Leach ST et al. Comment to: Changes of faecal microflora in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis 2013; 45: 177.
11. Nahidi L, Leach ST, Mitchell HM et al. Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int 2013; 2013: 909613.
12. Pryce-Millar E, Murch SH, Heuschkel RB et al. Enteral nutrition therapy in Crohn's disease changes the mucosal flora. J Pediatr Gastroenterol Nutr 2004; 39: S289.
13. Lionetti P, Callegari ML, Ferrari S et al. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005; 29: S184-S188.
14. Leach ST, Mitchell HM, Eng WR et al. Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease. Aliment Pharmacol Ther 2008; 28: 724-733.
15. Shiga H, Kajiura T, Shinozaki J et al. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis 2012; 44: 736-742.
16. Gerasimidis K, Bertz M, Hanske L et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis 2014; 20: 861-871.
17. D'Argenio V, Precone V, Casaburi G et al. An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol 2013; 108: 851-852.
18. Tjellstrom B, Hogberg L, Stenhammar L et al. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol 2012; 47: 1454-1459.
19. IBD Working Group of the European Society for Paediatric Gastroenterology Heptagology, NutritionInflammatory bowel disease in children and adolescents: recommendations for diagnosis-the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7.
20. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005 19: 5A-36A.
21. Hyams JS, Mandel F, Ferry GD et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992; 14: 216-222.
22. Griffiths RI, Whiteley AS, O'Donnell AG et al. Rapid method for coextraction of DNA and RNA from natural environments for analysis of ribosomal DNA- and rRNA-based microbial community composition. Appl Environ Microbiol 2000; 66: 5488-5491.
23. Andreotti R, Perez de Leon AA, Dowd SE et al. Assessment of bacterial diversity in the cattle tick Rhipicephalus (Boophilus) microplus through tag-encoded pyrosequencing. BMC Microbiol 2011; 11: 6.
24. Bailey MT, Dowd SE, Parry NM et al. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun 2010; 78: 1509-1519.
25. Dowd SE, Callaway TR, Wolcott RD et al. Evaluation of the bacterial diversity in the feces of cattle using 16S rDNA bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP). BMC Microbiol 2008; 8: 125.
26. Dowd SE, Delton Hanson J, Rees E et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care 2011; 20: 40-47.
27. Dowd SE, Sun Y, Wolcott RD et al. Bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP) for microbiome studies: bacterial diversity in the ileum of newly weaned Salmonella-infected pigs. Foodborne Pathog Dis 2008; 5: 459-472.
28. Gontcharova V, Youn E, Wolcott RD et al. Black Box Chimera Check (B2C2): a Windowsbased software for batch depletion of chimeras from bacterial 16S rRNA gene datasets. Open Microbiol J 2010; 4: 47-52.
29. DeSantis TZ, Hugenholtz P, Larsen N et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006; 72: 5069-5072.
30. Schloss PD, Westcott SL, Ryabin T et al. Introducing mothur: open-source, platformindependent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75: 7537-7541.
31. Quince C, Lanzen A, Curtis TP et al. Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods 2009; 6: 639-641.
32. Pruesse E, Quast C, Knittel K et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res 2007; 35: 7188-7196.
33. Cole JR, Chai B, Farris RJ et al. The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis. Nucleic Acids Res 2005; 33: D294-D296.
34. Clarke KR.. Non-parametric multivariate analyses of changes in community structure. Austr J Ecol 1993; 18: 117-143.
35. Hasan NA, Young BA, Minard-Smith AT et al. Microbial community profiling of human saliva using shotgun metagenomic sequencing. PLoS One 2014; 9: e97699.
36. Kaakoush NO, Day AS, Huinao KD et al. Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol 2012; 50: 3258-3266.
37. Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol 2011; 8: 152-168.
38. Manichanh C, Borruel N, Casellas F et al. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 2012; 9: 599-608.
39. Ohkusa T, Okayasu I, Ogihara T et al. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 2003; 52: 79-83.
40. Strauss J, Kaplan GG, Beck PL et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 2011; 17: 1971-1978.
41. Zhu Q, Jin Z, Wu W et al. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLoS One 2014; 9: e90849.
42. McConnell BB, Yang VW. The role of inflammation in the pathogenesis of colorectal cancer. Curr Colorectal Cancer Rep 2009; 5: 69-74.
43. Berry D, Schwab C, Milinovich G et al. Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis. ISME J 2012; 6: 2091-2106.
44. Jia W, Whitehead RN, Griffiths L et al. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 2010; 310: 138-144.
45. Duck LW, Walter MR, Novak J et al. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis 2007; 13: 1191-1201.
46. Ye J, Lee JW, Presley LL et al. Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice. Inflamm Bowel Dis 2008; 14: 1041-1050.
47. Palm NW, de Zoete MR, Cullen TW et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014; 158: 1000-1010.
48. Kamada N, Kim Y-G, Sham HP et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012; 336: 1325-1329.